Discontinuing oral anticoagulation after successful atrial fibrillation ablation is associated with a low incidence of thromboembolic events.
Does discontinuation of OAC after successful catheter ablation for atrial fibrillation safely prevent thromboembolic events compared to continued therapy?
Discontinuing OAC after successful atrial fibrillation ablation is associated with low thromboembolic event rates, but larger studies are needed to confirm net clinical benefit.
Absolute Event Rate: 0% vs 0%
This analysis reinforces that, across randomized data, the incidence of thromboembolic events in patients who discontinued OAC after successful ablation remained low. However, the evaluation of net clinical benefit is limited by the low number of events across all treatment arms, underscoring the need for larger studies with prolonged follow-up to further validate the safety of this strategy, particularly in higher-risk populations.
Rodriguez-Riascos et al. (Fri,) reported a other. Discontinuing oral anticoagulation after successful atrial fibrillation ablation is associated with a low incidence of thromboembolic events.